The rapid unwinding of China’s Covid restrictions last month triggered a wave of stockpiling of antiviral drugs including Paxlovid, but access to the treatment has been limited due to low domestic supply. That opened the door to a thriving black market for Indian generic versions and copies that turned out to be fake.